rituximab
not tagged
[]
ielsg37 randomized trial evaluating observation vs rt in pmbcl by andrew davies #17icml - rt can be safely omitted in patients with cmr after front-line treatment
- severe cardiac events &amp; second cancers occurred all in patients randomized to rt 
Research Fellow @MSKCancerCenter Hematologist @hospitalclinic #Lymphoma #CLL.